Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Exanthema × Minocycline × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

cyclopia sequence 10 Lung Neoplasms 3 Pain 2 Neoplasms, Plasma Cell 2 Multiple Myeloma 2 Head and Neck Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Sleepiness 1 Peripheral Nervous System Diseases 1 Parasomnias 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Laryngeal Diseases 1 Hypesthesia 1 Glioma 1 Fatigue 1 Exanthema 1 Esophageal Neoplasms 1 Depression 1 Colorectal Neoplasms 1 Carcinoma 1 Anxiety Disorders 1 Anorexia 1 Acute Pain 1

Interventions

benralizumab 1 Triamcinolone Acetonide 1 Tetracycline 1 Sirolimus 1 Panitumumab 1 Minocycline 1 Irinotecan 1 IFL protocol 1 Hydrocortisone 1 Gels 1 Fulvestrant 1 Erlotinib Hydrochloride 1 Dapsone 1 Clindamycin 1 Anti-Bacterial Agents 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00473083 2017-04-04

LUTRAERL

British Columbia Cancer Agency

Phase 2 Completed

150 enrolled 13 charts

Exanthema, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡